Möchten Sie immer auf dem neuesten Stand bleiben?

Total company second quarter 2021 revenue of approximately EUR 10.4 million (USD $12.4 million) increased 11.8% year-over-year; first half 2021 total company revenue of EUR 20.7 million (USD $24.8...

Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts LYON, France, July 20, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the...

Appointment brings highly experienced medical technology and commercialization leader to drive EDAP’s US expansion focus.Career accomplishments include 14 years at Intuitive Surgical, where he played...

Generated record first quarter revenue of EUR 10.3 million (USD 12.4 million), an increase of 35.4% year-over-yearIncreased gross margin year-over-year to 42.4%, contributing to a profitable...

Company to host conference call and webcast on Wednesday, May 12 at 8:30 am EDT LYON, France, May 4, 2021 - EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, today...

LYON, France, April 23, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its offering of American Depositary Shares...

LYON, France, April 22, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today the launch of a follow-on public offering of its...

Generated record fourth quarter revenue of EUR 15.4 million (USD 18.3 million), an increase of 28% year-over-year; HIFU revenue up 51% year-over-yearGenerated €41.7 million revenue and profitable...

Company to host conference call and webcast on Wednesday, March 31 at 8:30 am EDT LYON, France, March 23, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...

  Initiatives focused on making HIFU procedures broadly accessible to both Medicare and commercially insured patients  LYON, France, March 3, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the...